Medicus Pharma (NASDAQ:MDCX – Get Free Report) announced its quarterly earnings data on Friday. The company reported ($0.18) EPS for the quarter, topping the consensus estimate of ($0.32) by $0.14, Zacks reports.
Medicus Pharma Price Performance
MDCX opened at $3.13 on Friday. The stock has a 50-day simple moving average of $3.21. Medicus Pharma has a twelve month low of $1.80 and a twelve month high of $6.00.
Analysts Set New Price Targets
A number of research firms recently commented on MDCX. Maxim Group began coverage on shares of Medicus Pharma in a report on Tuesday, December 17th. They issued a “buy” rating and a $10.00 price target on the stock. Brookline Capital Management raised Medicus Pharma to a “strong-buy” rating in a research report on Monday, December 23rd.
Medicus Pharma Company Profile
Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.
Read More
- Five stocks we like better than Medicus Pharma
- Stock Analyst Ratings and Canadian Analyst Ratings
- MarketBeat Week in Review – 03/24 – 03/28
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What Does Downgrade Mean in Investing?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
